Literature DB >> 27340286

All Things Complement.

Joshua M Thurman1, Carla M Nester2,3.   

Abstract

The complement (C) cascade is an ancient system of proteins whose primary role is to initiate and modulate immune responses. During C activation, circulating proteins are cleaved and nascent cleavage fragments participate in a broad range of downstream innate and adaptive immune functions. Although the majority of these functions are either homeostatic or protective, a large body of experimental and clinical evidence also highlights a central role for the C system in the pathogenesis of many types of glomerular disease. From classic pathway activation in lupus nephritis to alternative pathway dysregulation in C3 glomerulopathy, our understanding of the spectrum of C involvement in kidney disease has expanded greatly in recent years. However, the characteristics that make the glomerulus so uniquely susceptible to C-mediated injury are not fully understood, and this remains an area of ongoing investigation. Several C inhibitors have been approved for clinical use, and additional C inhibitory drugs are in development. The use of these drugs in patients with kidney disease will expand our understanding of the benefits and limitations of C inhibition.
Copyright © 2016 by the American Society of Nephrology.

Entities:  

Keywords:  Complement Activation; Complement Inactivating Agents; Complement System Proteins; Humans; Kidney Diseases; Kidney Glomerulus; clinical immunology; complement; glomerular disease; glomerulonephritis; immune complexes; lupus nephritis

Mesh:

Substances:

Year:  2016        PMID: 27340286      PMCID: PMC5053787          DOI: 10.2215/CJN.01710216

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  95 in total

1.  A novel deletion in the RCA gene cluster causes atypical hemolytic uremic syndrome.

Authors:  Tara K Maga; Nicole C Meyer; Craig Belsha; Carla J Nishimura; Yuzhou Zhang; Richard J H Smith
Journal:  Nephrol Dial Transplant       Date:  2010-10-25       Impact factor: 5.992

2.  Soluble c5b-9 as a biomarker for complement activation in atypical hemolytic uremic syndrome.

Authors:  Fengxiao Bu; Nicole C Meyer; Yuzhou Zhang; Nicolo Ghiringhelli Borsa; Christie Thomas; Carla Nester; Richard J H Smith
Journal:  Am J Kidney Dis       Date:  2015-03-25       Impact factor: 8.860

3.  Immune complex glomerulonephritis in C4- and C3-deficient mice.

Authors:  R J Quigg; A Lim; M Haas; J J Alexander; C He; M C Carroll
Journal:  Kidney Int       Date:  1998-02       Impact factor: 10.612

Review 4.  Targeting the complement cascade: novel treatments coming down the pike.

Authors:  Joshua M Thurman; Moglie Le Quintrec
Journal:  Kidney Int       Date:  2016-06-18       Impact factor: 10.612

5.  Urinary C3dg and C5b-9 indicate active immune disease in human membranous nephropathy.

Authors:  P E Brenchley; B Coupes; C D Short; D J O'Donoghue; F W Ballardie; N P Mallick
Journal:  Kidney Int       Date:  1992-04       Impact factor: 10.612

Review 6.  Complement in immune and inflammatory disorders: therapeutic interventions.

Authors:  Daniel Ricklin; John D Lambris
Journal:  J Immunol       Date:  2013-04-15       Impact factor: 5.422

7.  C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation.

Authors:  Agustín Tortajada; Hugo Yébenes; Cynthia Abarrategui-Garrido; Jaouad Anter; Jesús M García-Fernández; Rubén Martínez-Barricarte; María Alba-Domínguez; Talat H Malik; Rafael Bedoya; Rocío Cabrera Pérez; Margarita López Trascasa; Matthew C Pickering; Claire L Harris; Pilar Sánchez-Corral; Oscar Llorca; Santiago Rodríguez de Córdoba
Journal:  J Clin Invest       Date:  2013-06       Impact factor: 14.808

8.  Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency.

Authors:  K Høgåsen; J H Jansen; T E Mollnes; J Hovdenes; M Harboe
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

9.  Localization of the complement regulatory proteins in the normal human kidney.

Authors:  S Ichida; Y Yuzawa; H Okada; K Yoshioka; S Matsuo
Journal:  Kidney Int       Date:  1994-07       Impact factor: 10.612

10.  Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains.

Authors:  Matthew C Pickering; Elena Goicoechea de Jorge; Rubén Martinez-Barricarte; Sergio Recalde; Alfredo Garcia-Layana; Kirsten L Rose; Jill Moss; Mark J Walport; H Terence Cook; Santiago Rodriguez de Córdoba; Marina Botto
Journal:  J Exp Med       Date:  2007-05-21       Impact factor: 14.307

View more
  26 in total

Review 1.  Kidney Diseases Associated With Alternative Complement Pathway Dysregulation and Potential Treatment Options.

Authors:  Prateek Sanghera; Mythili Ghanta; Fatih Ozay; Venkatesh K Ariyamuthu; Bekir Tanriover
Journal:  Am J Med Sci       Date:  2017-03-16       Impact factor: 2.378

Review 2.  Thrombotic Microangiopathy and the Kidney.

Authors:  Vicky Brocklebank; Katrina M Wood; David Kavanagh
Journal:  Clin J Am Soc Nephrol       Date:  2017-10-17       Impact factor: 8.237

3.  ABIN1 Determines Severity of Glomerulonephritis via Activation of Intrinsic Glomerular Inflammation.

Authors:  Erik A Korte; Dawn J Caster; Michelle T Barati; Min Tan; Shirong Zheng; Celine C Berthier; Frank C Brosius; Mark B Vieyra; Ryan M Sheehan; Michele Kosiewicz; Marcin Wysoczynski; Patrick M Gaffney; David J Salant; Kenneth R McLeish; David W Powell
Journal:  Am J Pathol       Date:  2017-09-19       Impact factor: 4.307

4.  Pericytes and immune cells contribute to complement activation in tubulointerstitial fibrosis.

Authors:  Sandhya Xavier; Ranjit K Sahu; Susan G Landes; Jing Yu; Ronald P Taylor; Srinivas Ayyadevara; Judit Megyesi; William B Stallcup; Jeremy S Duffield; Edimara S Reis; John D Lambris; Didier Portilla
Journal:  Am J Physiol Renal Physiol       Date:  2017-01-04

5.  Urine complement activation fragments are increased in patients with kidney injury after cardiac surgery.

Authors:  Jennifer Laskowski; Heather Thiessen Philbrook; Chirag R Parikh; Joshua M Thurman
Journal:  Am J Physiol Renal Physiol       Date:  2019-07-17

Review 6.  [The complement system-a "hot topic" not only for kidney diseases].

Authors:  Kerstin Amann; Christoph Daniel; Maike Büttner-Herold
Journal:  Pathologe       Date:  2020-05       Impact factor: 1.011

7.  Complement factor H protects mice from ischemic acute kidney injury but is not critical for controlling complement activation by glomerular IgM.

Authors:  Lindsey Goetz; Jennifer Laskowski; Brandon Renner; Matthew C Pickering; Liudmila Kulik; Jelena Klawitter; Erik Stites; Uwe Christians; Johan van der Vlag; Kameswaran Ravichandran; V Michael Holers; Joshua M Thurman
Journal:  Eur J Immunol       Date:  2018-02-22       Impact factor: 5.532

Review 8.  Dominant C3 glomerulopathy: new roles for an old actor in renal pathology.

Authors:  Nicola Pirozzi; Antonella Stoppacciaro; Paolo Menè
Journal:  J Nephrol       Date:  2017-11-18       Impact factor: 3.902

Review 9.  The role of the alternative pathway of complement activation in glomerular diseases.

Authors:  Emilia Łukawska; Magdalena Polcyn-Adamczak; Zofia I Niemir
Journal:  Clin Exp Med       Date:  2018-02-15       Impact factor: 3.984

Review 10.  The renaissance of complement therapeutics.

Authors:  Daniel Ricklin; Dimitrios C Mastellos; Edimara S Reis; John D Lambris
Journal:  Nat Rev Nephrol       Date:  2017-12-04       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.